Jugder, Ganzug, et al. “The Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise Between Sensitivity and Specificity”. Central Asian Journal of Medical Sciences, vol. 4, no. 3, Sept. 2018, pp. 230-7, doi:10.24079/cajms.2018.09.009.